Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Xilio Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
Revenues0.00.00.014.3
            Revenue growth  -100.0% 
Cost of goods sold0.00.00.019.0
Gross profit0.00.00.0-4.8
            Gross margin   -33.5%
Research and development59.251.243.9 
General and administrative29.923.910.74.8
EBIT-89.1-74.6-54.4-19.0
            EBIT margin   -133.5%
Pre-tax income-88.2-75.8-55.2-17.3
Income taxes0.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%
Net income-88.2-75.8-55.2-17.3
            Net margin   -121.4%
 
Diluted EPS($3.22)($13.52)($105.42) 
Shares outstanding (diluted)27.45.60.5 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy